Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Abcam accquires Californian antibodies manufacturer

Mon, 28th Jan 2019 08:35

(Sharecast News) - Antibody supplier Abcam has acquired Californian monoclonal antibodies manufacturer Calico Biolabs for an undisclosed amount.Abcam said on Monday that the addition of Calico to the group would expand its already leading position in rabbit monoclonal antibodies - bringing a small catalogue of ready-made CAL antibodies for immunohistochemistry in addition to custom development services.While the AIM-listed firm did not disclose any financial terms of the deal, Abcam's board expects the transaction to "have a minimal impact on revenue and earnings".Abcam's John Baker said: "The acquisition of Calico represents execution of our strategy to provide the best and highest quality products to our diagnostic, biopharmaceutical and research customers.""By incorporating Calico's product portfolio and custom services, Abcam expands its offering of rabbit monoclonals for IHC, allowing development of more products for their most important targets, faster."As of 0835 GMT, Abcam shares had slipped 1.70% to 1,216p.
More News
23 Oct 2013 09:49

BROKER RATINGS CHANGES: Six Brokers Raise ARM Price Target

Read more
23 Oct 2013 09:28

Wednesday broker round-up UPDATE

Abcam: Numis downgrades to add with a target price of 570p. ARM Holdings: Deutsche Bank increases target price from 1080p to 1130p and maintains a buy recommendation. JP Morgan raises target price from 625p to 750p and leaves its neutral rating unaltered. Societe Generale ups target price from 640p

Read more
10 Oct 2013 17:16

DIRECTOR DEALINGS: ABCAM Manager Exercises Options, Sells Shares

Read more
7 Oct 2013 07:58

Monday broker round-up UPDATE

Abcam: Investec raises target price from 504p to 552p and retains a buy recommendation. Britvic: Nomura raises target price from 630p to 680p maintaining its buy recommendation. Cranswick: Panmure Gordon reduces target price from 1200p to 1140p and maintains a hold recommendation. First Group: Je

Read more
4 Oct 2013 13:56

DIRECTOR DEALINGS: Abcam Chief Executive Interest In Company Declines

Read more
24 Sep 2013 12:56

DIRECTOR DEALINGS: Abcam Executives Awarded Matching Shares

Read more
16 Sep 2013 14:23

DIRECTOR DEALINGS: Abcam Director, Manager Dispose Of Interests In Shares

Read more
10 Sep 2013 13:24

DIRECTOR DEALINGS - Abcam Executives To Be Awarded Options

Read more
10 Sep 2013 07:53

Abcam continues to power ahead despite market pressures

Spending pressures in its key markets only slightly slowed clinical research tools supplier Abcam as it continued its double-digit growth from top to bottom line. Revenue rose 25% to £122.2m, only minutely behind consensus forecasts, but pre-tax profits beat analyst estimates by rising 21% to £46.

Read more
10 Sep 2013 07:51

Abcam Reports Jump In Profits As It Overcomes Difficult R&D Markets

Read more
11 Apr 2013 16:13

Low & Bonar CEO and Finance Director trade in shares from LTIP

Steve Good, the Group Chief Executive of materials group Low & Bonar, has sold a significant portion of the 1.4m shares that recently vested under the company's long-term incentive plan. Of these, he sold 908,676, taking his total stake in the company to 919,098. Mike Holt, the group's Finance Di

Read more
20 Mar 2013 08:53

Wednesday broker round-up UPDATE

Abcam: Canaccord Genuity moves target price from 344p to 358p, but still recommends selling. Antofagasta: Jefferies cuts target price from 1350p to 1100p, while keeping a hold recommendation. ASOS: Cantor Fitzgerald raises target price from 2500p to 2900p reiterating a hold recommendation. Panmure

Read more
19 Mar 2013 15:59

Bwin.party non-exec makes double purchase

bwin.party digital entertainment announced Tuesday that one of its Non-Executive Directors has made two purchases following a report by the company admitting profits had suffered a sharp decline. Geoff Baldwin on Friday purchased 226,000 shares at 147.83p, followed by a further 74,000 on Monday at

Read more
12 Mar 2013 07:19

Tuesday broker round-up UPDATE

Abcam:Investec shifts target price from 484p to 487p and keeps a buy recommendation. Admiral Group: UBS ups target price from 1200p to 1275p and reiterates a neutral rating. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite: Numis reduce

Read more
5 Mar 2013 07:15

Tuesday broker round-up UPDATE

Abcam: Investec raises target price from 466p to 484p and keeps a buy recommendation. Numis revises target price from 470p to 530p and maintains its buy ratng. Access Intelligence: Merchant Securities initiates with a target price of 7p and a buy recommendation. Amlin: Canaccord Genuity raises tar

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.